WallStreetZenWallStreetZen

NASDAQ: CGON
Cg Oncology Inc Stock Forecast, Predictions & Price Target

Analyst price target for CGON

Based on 4 analysts offering 12 month price targets for Cg Oncology Inc.
Min Forecast
$42.00+2.44%
Avg Forecast
$61.75+50.61%
Max Forecast
$75.00+82.93%

Should I buy or sell CGON stock?

Based on 4 analysts offering ratings for Cg Oncology Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
1 analysts 25%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CGON stock forecasts and price targets.

CGON stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-04
lockedlocked$00.00+00.00%2024-02-20
lockedlocked$00.00+00.00%2024-02-20
lockedlocked$00.00+00.00%2024-02-20

1 of 1

Forecast return on equity

Is CGON forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is CGON forecast to generate an efficient return on assets?

CGON revenue forecast

What is CGON's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$3.0M+1,370.59%
Avg 2 year Forecast
$32.5M+15,831.37%
Avg 3 year Forecast
$81.4M+39,816.67%
CGON's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CGON revenue growth forecast

How is CGON forecast to perform vs Biotechnology companies and vs the US market?
Company
630.93%
Industry
37.85%
Market
9.96%
CGON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CGON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CGON vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CGON$41.00$61.75+50.61%Strong Buy
ARWR$22.12$49.40+123.33%Buy
ACLX$51.92$79.33+52.80%Strong Buy
MOR$18.04$12.13-32.79%Buy
MLTX$42.49$77.00+81.22%Strong Buy

Cg Oncology Stock Forecast FAQ

Is Cg Oncology Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CGON) stock is to Strong Buy CGON stock.

Out of 4 analysts, 2 (50%) are recommending CGON as a Strong Buy, 1 (25%) are recommending CGON as a Buy, 1 (25%) are recommending CGON as a Hold, 0 (0%) are recommending CGON as a Sell, and 0 (0%) are recommending CGON as a Strong Sell.

If you're new to stock investing, here's how to buy Cg Oncology stock.

What is CGON's revenue growth forecast for 2024-2026?

(NASDAQ: CGON) Cg Oncology's forecast annual revenue growth rate of 630.93% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.85%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.96%.

Cg Oncology's revenue in 2024 is $204,000.On average, 1 Wall Street analysts forecast CGON's revenue for 2024 to be $199,908,756, with the lowest CGON revenue forecast at $199,908,756, and the highest CGON revenue forecast at $199,908,756. On average, 1 Wall Street analysts forecast CGON's revenue for 2025 to be $2,165,678,190, with the lowest CGON revenue forecast at $2,165,678,190, and the highest CGON revenue forecast at $2,165,678,190.

In 2026, CGON is forecast to generate $5,426,190,000 in revenue, with the lowest revenue forecast at $2,598,813,828 and the highest revenue forecast at $8,253,566,173.

What is CGON's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CGON) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CGON's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CGON price target, the average CGON price target is $61.75, with the highest CGON stock price forecast at $75.00 and the lowest CGON stock price forecast at $42.00.

On average, Wall Street analysts predict that Cg Oncology's share price could reach $61.75 by Apr 4, 2025. The average Cg Oncology stock price prediction forecasts a potential upside of 50.61% from the current CGON share price of $41.00.

What is CGON's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CGON) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.